At a glance
- Originator Otsuka Pharmaceutical
- Class Cardiotonics; Piperazines; Quinolones; Small molecules; Vasodilators
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Acute heart failure